Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2

Aim. To study interconnections between epicardial adipose tissue thickness (EATt), parameters of glucose metabolism/insulin, C-reactive protein (hsCRP), serum adipokines and severity of coronary artery disease (CAD) depending on the presence of diabetes mellitus type 2 (DM 2); to determine significa...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Olga A. Koshelskaya, Olga A. Kharitonova, Irina V. Kologrivova, Tatiana E. Suslova, Natalia Yu. Margolis, Ekaterina K. Tereshenkova, Anastasiia N. Rybina, Rostislav S. Karpov
Formato:	article
Lenguaje:	RU
Publicado:	"Consilium Medicum" Publishing house 2021
Materias:	coronary atherosclerosis diabetes mellitus epicardial adipose tissue thickness Medicine R
Acceso en línea:	https://doaj.org/article/166723aec2824e71a14d69bed07808af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:166723aec2824e71a14d69bed07808af
record_format	dspace
spelling	oai:doaj.org-article:166723aec2824e71a14d69bed07808af2021-12-01T12:22:36ZMetabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 20040-36602309-534210.26442/00403660.2021.09.201032https://doaj.org/article/166723aec2824e71a14d69bed07808af2021-09-01T00:00:00Zhttps://ter-arkhiv.ru/0040-3660/article/viewFile/82964/63438https://doaj.org/toc/0040-3660https://doaj.org/toc/2309-5342Aim. To study interconnections between epicardial adipose tissue thickness (EATt), parameters of glucose metabolism/insulin, C-reactive protein (hsCRP), serum adipokines and severity of coronary artery disease (CAD) depending on the presence of diabetes mellitus type 2 (DM 2); to determine significant markers of CAD severity in patients with DM 2. Materials and methods. The study involved 106 patients with CAD (m/f 64/42, 60.96.8 years), including patients with DM 2 (group 1, n=35) and non-diabetic patients (group 2, n=71). Severity of CAD was evaluated according to angiography data with calculation of Gensini Score (GS). EATt was assessed via echocardiography. Serum levels of glucose/insulin metabolism parameters, lipid fractions, hsCRP and adipokines were evaluated. Clinical parameters, including GS, did not differ between groups. Results. EAT thickness median was elevated in gr.1 (5.1 mm vs. 4.4 mm in group 2), while adiponectin levels were decreased (6.55 g/ml vs. 7.71 g/ml). Linear regression of body mass index and resistin levels on EATt was revealed in gr.1; in gr.2 EATt linearly increased with waist circumference increment when EATt6 mm. Linear regression of EATt on GS was revealed in gr.1 when EATt8 mm, while linear regression in the whole GS range was obtained for HDL-C and hsCRP levels. Conclusion. Study results demonstrate differences in mechanisms of deposition and functioning of epicardial and abdominal adipose tissue depending on the presence or absence of diabetic status. Patients with DM2 are characterized by the excessive EAT deposition and decrease of serum adiponectin levels compared to non-diabetic patients in the equal conditions. Independent markers of CAD severity in DM 2 are decreased HDL-C and increased hsCRP levels, but not EATt.Olga A. KoshelskayaOlga A. KharitonovaIrina V. KologrivovaTatiana E. SuslovaNatalia Yu. MargolisEkaterina K. TereshenkovaAnastasiia N. RybinaRostislav S. Karpov"Consilium Medicum" Publishing housearticlecoronary atherosclerosisdiabetes mellitusepicardial adipose tissue thicknessMedicineRRUТерапевтический архив, Vol 93, Iss 9, Pp 1030-1036 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	coronary atherosclerosis diabetes mellitus epicardial adipose tissue thickness Medicine R
spellingShingle	coronary atherosclerosis diabetes mellitus epicardial adipose tissue thickness Medicine R Olga A. Koshelskaya Olga A. Kharitonova Irina V. Kologrivova Tatiana E. Suslova Natalia Yu. Margolis Ekaterina K. Tereshenkova Anastasiia N. Rybina Rostislav S. Karpov Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
description	Aim. To study interconnections between epicardial adipose tissue thickness (EATt), parameters of glucose metabolism/insulin, C-reactive protein (hsCRP), serum adipokines and severity of coronary artery disease (CAD) depending on the presence of diabetes mellitus type 2 (DM 2); to determine significant markers of CAD severity in patients with DM 2. Materials and methods. The study involved 106 patients with CAD (m/f 64/42, 60.96.8 years), including patients with DM 2 (group 1, n=35) and non-diabetic patients (group 2, n=71). Severity of CAD was evaluated according to angiography data with calculation of Gensini Score (GS). EATt was assessed via echocardiography. Serum levels of glucose/insulin metabolism parameters, lipid fractions, hsCRP and adipokines were evaluated. Clinical parameters, including GS, did not differ between groups. Results. EAT thickness median was elevated in gr.1 (5.1 mm vs. 4.4 mm in group 2), while adiponectin levels were decreased (6.55 g/ml vs. 7.71 g/ml). Linear regression of body mass index and resistin levels on EATt was revealed in gr.1; in gr.2 EATt linearly increased with waist circumference increment when EATt6 mm. Linear regression of EATt on GS was revealed in gr.1 when EATt8 mm, while linear regression in the whole GS range was obtained for HDL-C and hsCRP levels. Conclusion. Study results demonstrate differences in mechanisms of deposition and functioning of epicardial and abdominal adipose tissue depending on the presence or absence of diabetic status. Patients with DM2 are characterized by the excessive EAT deposition and decrease of serum adiponectin levels compared to non-diabetic patients in the equal conditions. Independent markers of CAD severity in DM 2 are decreased HDL-C and increased hsCRP levels, but not EATt.
format	article
author	Olga A. Koshelskaya Olga A. Kharitonova Irina V. Kologrivova Tatiana E. Suslova Natalia Yu. Margolis Ekaterina K. Tereshenkova Anastasiia N. Rybina Rostislav S. Karpov
author_facet	Olga A. Koshelskaya Olga A. Kharitonova Irina V. Kologrivova Tatiana E. Suslova Natalia Yu. Margolis Ekaterina K. Tereshenkova Anastasiia N. Rybina Rostislav S. Karpov
author_sort	Olga A. Koshelskaya
title	Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
title_short	Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
title_full	Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
title_fullStr	Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
title_full_unstemmed	Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
title_sort	metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2
publisher	"Consilium Medicum" Publishing house
publishDate	2021
url	https://doaj.org/article/166723aec2824e71a14d69bed07808af
work_keys_str_mv	AT olgaakoshelskaya metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT olgaakharitonova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT irinavkologrivova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT tatianaesuslova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT nataliayumargolis metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT ekaterinaktereshenkova metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT anastasiianrybina metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2 AT rostislavskarpov metabolicinflammatoryandimagingbiomarkersinevaluationofcoronaryatherosclerosisseverityinpatientswithcoronaryarterydiseaseanddiabetesmellitustype2
_version_	1718405160290484224

Metabolic, inflammatory and imaging biomarkers in evaluation of coronary atherosclerosis severity in patients with coronary artery disease and diabetes mellitus type 2

Ejemplares similares